Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Activaero GmbH College Hill
Activaero Cooperates with Bayer HealthCare in the Development of Inhaled Treatments
October 17th, 2008
Activaero GmbH, the world leader in controlled breathing technologies for inhaled therapeutic agents, announced a licensing and option agreement with Bayer HealthCare AG on the development of inhaled treatments. Under the terms of the agreement, Activaero will receive an upfront payment and in case the option will be exerted subsequently milestone payments as well. Dr. Gerhard Scheuch, Founder and CEO of Activaero commented: "This licensing deal represents a major milestone for Activaero and together with our scientific team, we look forward to supporting Bayer HealthCare throughout the upcoming development. We believe that pulmonary administration of drugs has a huge...
Source: Health Business Week (2008-10-17)
|
